Merck KGaA Profit Beats Estimates on Cost-Cutting

May 14 (Bloomberg) -- Merck KGaA, the German maker of cancer drug Erbitux, said first-quarter profit rose on higher-than-expected savings from a reorganization program, and forecast it will achieve 2014 targets a year ahead of schedule. Mark Barton reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Amazon's Presence at the Oscars
32:56 - Hollywood's biggest weekend is just around the corner with the 89th annual Academy Awards on Sunday. We see some familiar names like Meryl Streep and Ryan Gosling, but there is one new player grabbing attention. Bloomberg's Kaitlin Meehan reports on “Bloomberg Technology.” (Source: Bloomberg)
  • The Self-Driving Car Fight Between Google and Uber
  • Lucid Motors Aims to Rival Tesla
  • Personal Capital CEO Says Banks Need to Change Attitude